AzTrials
AzTrials

Knee OsteoarthritisIWALQQ-OANCT03064139

Improving Walking Quality and Quantity in Osteoarthritis (IWALQQ-OA)

A study testing MCG and SCG in people with Knee Osteoarthritis, run by Boston University Charles River Campus at 1 site in United States.

Terminated

Stopped early. The study ended before it was planned to and will not resume.

Official record
Search all trials

Trial summary

This study evaluates the feasibility of a mindful walking intervention for management of knee osteoarthritis. Participants will be randomly assigned to receive one of two interventions i.e. mindful walking intervention or a self-care intervention. Read more about this study

Who is it for?
Ages 50 to 80 years
Conditions the study is for
Knee Osteoarthritis
What is being tested?
MCG and SCG
Could I receive a placebo?
No, everyone receives an active treatment
How many people
47 participants
Where
1 siteUnited States
Study dates
7 Mar 2019to 18 Mar 2021
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 50 to 80 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • age 50-80 years
  • BMI ≤40 kg/m2
  • Meet American College of Rheumatology clinical and/or clinical+radiographic criteria for knee osteoarthritis
  • Knee pain score ≥ 4 during last week
  • Predominantly medial knee pain
  • Predominantly medial knee radiographic osteoarthritis with or without radiographic patellofemoral osteoarthritis
Show all 10Show fewer
  • Ability to ambulate for a minimum of 20 minutes, without any assistive device
  • Available for the study duration
  • Own a smartphone
  • Can speak and understand English

Who cannot join

  • Contraindications to exercise
  • Using orthotics for knee pain such as knee braces, wedge insoles
  • Knee injection in previous 3-months
  • Currently receiving physical therapy for knee pain
  • Planning major treatment for knee pain (e.g., physical therapy, surgery) in next 6 months
  • Self-reported joint diseases like rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, gout, etc.
Show all 10Show fewer
  • Self-reported total joint replacement in any lower extremity joint
  • Self-reported neurological conditions like stroke, Parkinson's disease, etc.
  • Self-reported muscular disease like muscle dystrophy
  • Self-reported musculoskeletal or neurologic conditions that affect gait.

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Boston University

    Boston, Massachusetts, 02215

Other trials in United States

About this study

Official title: Improving Walking Quality and Quantity in Osteoarthritis (IWALQQ-OA): A Feasibility Study

This study evaluates the feasibility of a mindful walking intervention for management of knee osteoarthritis. Participants will be randomly assigned to receive one of two interventions i.e. mindful walking intervention or a self-care intervention.

Read the detailed description

People with knee osteoarthritis have low levels of physical activity, especially walking activity. They also walk with abnormal walking biomechanics that are associated with greater knee loading. Therefore, it is important to increase the levels of walking activity in people with knee osteoarthritis, but also change their walking patterns to reduce knee loading.

This study will last 12 months and participants will be randomized into 2 groups. For the first 6-months, half of the participants will attend sessions at a community location that include training in mindful walking technique. The other half will meet for the same frequency and duration at a community location for education on osteoarthritis and its management (focusing on symptom management, importance of physical activity, weight management, etc.). Both groups will also receive a wrist-worn activity monitor and a smartphone application that they will use throughout the study. After 6-months all participants will be allowed to practice on their own.

All participants will complete gait analysis, knee MRI, questionnaires, physical function assessment at baseline and at 6-months. All participants will also complete questionnaires at 3,9, and 12 months. Weekly physical activity and knee pain data will be collected using the mobile health technology for 12- months.

Being tested
MCG, SCG
Keywords
physical activity, gait, biomechanics, mindfulness
Medical subject headings
Osteoarthritis, Knee, Motor Activity

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • MCGBehavioural

    Community-based in person group training n mindful walking over 11 sessions in 6-months+ Activity monitor with feedback on activity levels

  • SCGBehavioural

    Community-based in person group education in management of knee osteoarthritis (importance of physical activity, weight management, etc.) over 11 sessions in 6 months + Activity monitor with feedback on activity levels

Study groups in NCT03064139
Study groupRoleWhat they receive
MCG - Mindful WalkingExperimentalParticipants will be trained in mindful walking technique
Receives: Behavioral: MCG
SCG - Education and Self-CareActive comparatorParticipants will receive education in self-management of knee OA
Receives: Behavioral: SCG

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Adherence (in %)

    Measured as % of in-person training sessions attended by participants

    Measured: 6-months

  2. Retention (in %)

    Measured as the % of participants returning for the post-intervention assessment

    Measured: 6-months

Secondary outcomes (3)
  1. Medial knee contact force during walking (in Newton)

    Medial knee contact force derived using an EMG-Driven musculoskeletal model

    Measured: Change from baseline to 6-months

  2. Average Daily Activity Count

    Measured using an activity monitor worn by the participants

    Measured: Change from baseline to 6-months

  3. Knee injury and Osteoarthritis Outcome Score (KOOS) Pain Subscale

    Patient-reported outcome

    Measured: Change from baseline to 6-months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted24 Feb 2017
  2. Study start7 Mar 2019
  3. Primary completion22 Sep 2020
  4. Study completion18 Mar 2021

Why it stopped: Study terminated early due to COVID-19. Interim data analyses in progress.

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
47 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03064139
Sponsor's protocol ID
4428E
Acronym
IWALQQ-OA
Status last verified
Jul 2022
First submitted
14 Feb 2017
Last updated
20 Jul 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Publications

  • Lee S, Neogi T, Costello KE, Senderling B, Stefanik JJ, Frey-Law L, Kumar D. Association of mechanical temporal summation of pain with muscle co-contraction during walking in people with knee osteoarthritis. Clin Biomech (Bristol). 2023 Dec;110:106105. doi: 10.1016/j.clinbiomech.2023.106105. Epub 2023 Sep 22.

    PubMed 37778085

Questions about this trial

What is this clinical trial studying?

A study testing MCG and SCG in people with Knee Osteoarthritis, run by Boston University Charles River Campus at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 10 inclusion and 10 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: stopped early, as of the sponsor's last update on 20 Jul 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study was stopped early (reason given: Study terminated early due to COVID-19. Interim data analyses in progress.). Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Adherence (in %) (time frame: 6-months). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT03064139, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 20 Jul 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in